Rapamycin, Atorvastatin Trial, Biomarkers, and more - Dr. Issam Awad, University of Chicago

Dr. Issam Awad, cerebrovascular neurosurgeon and Chair of the Angioma Alliance Scientific Advisory Board, offers research and clinical trial updates. He discusses the latest PIK3CA research, rapamycin as a treatment for CCM, news from the atorvastatin trial and biomarker development, and COVID and CCM findings.

[@davision647]

Thank you

[@quasarhi]

Whats the latest ?

[@ats89117]

Good content, but worst green screen ever for Dr. Awad...

[@62romildo]

Perdi a reunião foi uma pena